Calum Kerr of CCC was honoured to visit the pleasant, calming surroundings of the China Resources University Campus in Baiyangdian District. Calum said “The facilities and atmosphere at the Campus are ideally suited to facilitate a first class learning environment”
Cancer Care Commission (CCC) fully supports the Chinese Government’s and National Cancer Centre’s (NCC) strategy to make cancer drugs more affordable to the general public. CCC participated in the UK Trade Mission to China in association with NCC, where this aspiration was highlighted. CCC President, Professor David Kerr stated “This is a major step towards addressing the burden of cancer in China. This decision is to be applauded.”
China approves 17 anti-cancer drugs for medical insurance coverage
SHANGHAI (Reuters) – China has approved 17 anti-cancer drugs for inclusion in its national health insurance system, the government said on Wednesday, part of its efforts to make cancer treatment more affordable as the number of cases increases.
China’s State Medical Insurance Administration has been in negotiations with domestic and overseas pharmaceutical companies to lower prices and put more cancer drugs on the list of medicines eligible for reimbursement.
China’s cancer rates have been soaring, driven by growing numbers of over-60s, heavy smoking among men and exposure to pollution. The National Cancer Center said last year there were 4.29 million new cases every year and 2.81 million deaths.
China has vowed to improve the five-year cancer survival rate by 15 percentage points by 2030. The rate stood at 30 percent in 2015.
MSP Miles Briggs, Shadow Cabinet Secretary for Health and Sport and co-convener of Parliamentary Cross Party group on cancer gave a keynote speech at the IFQCC18, Keble College, Oxford. Miles gave an overview of cancer management in Scotland and highlighted the challenges ahead. Miles participated in a panel discussion on the global cancer burden and put forward his Politician’s opinion on ….’Can policy drive real improvements’. The session was well received by the international audience.
IFQCC delegates were impressed by the standards of the Oral Abstract presentations at Keble College, Oxford. The judges awarded the 1st and 2nd Place to: George Tran (1st) and Dr Ashwaq Al Olayan (2nd). Well done to all the presenters .
Calum Kerr was surprised (and somewhat startled) to come face to face with a larger than life banner, when he was speaking of the importance of Accreditation at a conference of Hospital Directors and Heads of Oncology at Wuhan No.2 Hospital in early August.
In May / June of this year, Professor Kerr visited Wuhan City in Hubei Province, along with colleagues from POCC. His itinerary included meeting key healthcare providers, giving keynote lectures and developing an early screening programme and referral system, establishing a ‘Primary Care’ infrastructure. This visit is part of the Cancer Care Commission development programme for cancer care, with our partner; China Resources Phoenix, the largest Private Health Care provider in China.